Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis

OBJECTIVE: To compare the efficacy and safety of Levetiracetam (LEV) and Oxcarbazepine (OXC) as monotherapy for the treatment of newly diagnosed focal epilepsy. METHODS: We searched PubMed, Cochrane Library, EMBASE, and Google Scholar from January 1, 2000 to May 11, 2022, with no language restrictio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kharel, Sanjeev, Ojha, Rajeev, Khanal, Surendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660411/
https://www.ncbi.nlm.nih.gov/pubmed/36184821
http://dx.doi.org/10.1002/brb3.2779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660411/
https://www.ncbi.nlm.nih.gov/pubmed/36184821
http://dx.doi.org/10.1002/brb3.2779

Ejemplares similares